CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionCurrent ratio is 14.73×, higher than 95% of its Medical Instruments & Supplies peers (median 2.2×)
- FinancialsAltman Z-Score 7.23: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.33%
Annual Rate
CNY 0.06Paid annual
Payout Ratio
40.0%Sustainable
Last Ex-Dividend
Jun 18, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.93BCNY885.51M · vs all stocks (USD)
Trailing P/E
119.21xvs Medical Instruments & Supplies peers
Revenue (TTM)
669.57MCNY99.95M · vs all stocks (USD)
Profit Margin
7.19%vs Medical Instruments & Supplies peers
Beta
0.5100xvs all stocks
52-Week Change
-17.53%vs all stocks
Market Capitalization
5.93BCNY885.51M · vs all stocks (USD)
Enterprise Value
2.67BCNY398.87M · vs all stocks (USD)
Trailing P/E
119.21xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
8.59xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.36xvs Medical Instruments & Supplies peers
Enterprise to Revenue
3.99xvs Medical Instruments & Supplies peers
Gross Margin
21.70%vs Medical Instruments & Supplies peers
Profit Margin
7.19%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-0.59%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
1.15%vs Medical Instruments & Supplies peers
Revenue (TTM)
669.57MCNY99.95M · vs all stocks (USD)
Revenue per Share (TTM)
2.17CNYUpdated Sep 22, 2026Quarterly Revenue Growth
2.30%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
164.02MCNY24.48M · vs all stocks (USD)
EBITDA (TTM)
105.67MCNY15.77M · vs all stocks (USD)
Net Income (TTM)
48.17MCNY7.19M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
38.70%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
65.57MCNY9.79M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
25.00MCNY3.73M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0560CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.33%vs all stocks
Payout Ratio
40.00%vs Medical Instruments & Supplies peers
Revenue
628.32MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
471.72MCNYFY2025 · Dec 31, 2025Gross Profit
156.60MCNYFY2025 · Dec 31, 2025Operating Income
11.47MCNY1.71M · vs all stocks (USD)
Pre-tax Income
45.52MCNYFY2025 · Dec 31, 2025Income Tax Expense
2.75MCNYFY2025 · Dec 31, 2025Net Income
42.78MCNYFY2025 · Dec 31, 2025EBIT
45.59MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
105.67MCNYFY2025 · Dec 31, 2025Research & Development
58.17MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
22.92MCNYFY2025 · Dec 31, 2025Other Operating Expenses
8.38MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
9.63MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
64.77KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1200CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1200CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
356.48MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
356.48MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
42.78MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
92.96MCNYFY2025 · Dec 31, 2025Free Cash Flow
62.23MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.52BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
42.78MCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.89MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-21.26MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
67.55MCNYFY2025 · Dec 31, 2025Capital Expenditures
-30.73MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.10BCNYFY2025 · Dec 31, 2025Sale of Investments
1.81BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
681.62MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-49.14MCNYFY2025 · Dec 31, 2025Other Financing Charges
-672.71KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-49.82MCNYFY2025 · Dec 31, 2025Shares Outstanding
344.50MSharesUpdated Sep 22, 2026Float Shares
91.71MSharesUpdated Sep 22, 2026% Held by Insiders
73.40%vs all stocks
% Held by Institutions
3.12%vs all stocks
Total Cash (MRQ)
3.08BCNY459.39M · vs all stocks (USD)
Total Cash per Share (MRQ)
8.93CNYUpdated Sep 22, 2026Total Debt (MRQ)
0.00CNYvs all stocks (USD)
Total Debt to Equity (MRQ)
0.00xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
14.73xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
12.24CNYUpdated Sep 22, 2026Total Assets
4.81BCNY718.34M · vs all stocks (USD)
Total Current Assets
3.90BCNYFY2025 · Dec 31, 2025Total Liabilities
584.78MCNYFY2025 · Dec 31, 2025Total Non-current Assets
909.81MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
286.97MCNYFY2025 · Dec 31, 2025Total Current Liabilities
297.81MCNYFY2025 · Dec 31, 2025Cash
2.11BCNYFY2025 · Dec 31, 2025Cash Equivalents
405.51MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.52BCNYFY2025 · Dec 31, 2025Accounts Receivable
608.17MCNYFY2025 · Dec 31, 2025Inventory
156.57MCNYFY2025 · Dec 31, 2025Accounts Payable
250.21MCNYFY2025 · Dec 31, 2025Short-term Debt
452.94KCNYFY2025 · Dec 31, 2025Other Current Liabilities
603.60KCNYFY2025 · Dec 31, 2025Common Stock (Book)
344.50MCNYFY2025 · Dec 31, 2025Retained Earnings
271.40MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.23BCNY631.05M · vs all stocks (USD)
52-Week Low
13.68CNYUpdated Sep 22, 202652-Week High
24.14CNYUpdated Sep 22, 202652-Week Change
-17.53%vs all stocks
Beta
0.5100xvs all stocks
50-Day MA
16.12CNYUpdated Sep 22, 2026200-Day MA
18.94CNYUpdated Sep 22, 2026Avg 10-Day Volume
4.99MSharesUpdated Sep 22, 2026Avg 30-Day Volume
4.33MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.1400CNYUpdated Sep 22, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 14.73×, higher than 95% of its Medical Instruments & Supplies peers (median 2.2×)Significant
Current ratio: 14.73Industry median: 2.20Industry P95: 10.55Peers compared: 62.00
Debt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.23×)Notable
Debt-to-equity: 0.00Industry median: 0.23Industry P5: 0.00Peers compared: 62.00
Financial Health
Altman Z-Score 7.23: safe zoneNotable
Altman Z-Score: 7.23
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Arrow Home Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Hongchang Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Guangdong Guanhao High-Tech Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hubei Tech Semiconductors Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Daoming Optics & Chemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Hengong Precision Equipment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Xinjiang Qingsong Building Materials & Chemicals Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Nanjing Redsun Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Zhejiang Jw Precision Machinery Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Zhejiang Zhengguang Industrial Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Hangzhou Onechance Technology Co., Ltd.
3 interpretationsCash Elevated Relative to Current Liabilities and Total AssetsClose Below 40W SMA With ProfitabilityLiquidity Ratios Elevated
Shanghai New Centurion Net-A
3 interpretationsCash Elevated Relative to Current Liabilities and Total AssetsClose Below 40W SMA With ProfitabilityLiquidity Ratios Elevated
Beijing Jingyeda Technology Co., Ltd.
3 interpretationsCash Elevated Relative to Current Liabilities and Total AssetsClose Below 40W SMA With ProfitabilityLiquidity Ratios Elevated